VasoGnosis
Regulation Crowdfunding offering on SeedInvest (SI Securities)
$114,531
of $600,000 goal
19.1% funded
About the offering
VasoGnosis has developed an AI-powered diagnostic and surgical planning software platform for neurovascular diseases, which will assist neurosurgeons and interventional neuroradiologists to make better decisions impacting quality of life. Today, 150M+ people are suffering from a brain aneurysm globally. Each year 500K people die because of strokes which, in most cases, are caused by aneurysm. VasoGnosis's mission is to save brains – so people can keep living independently. Our AI-powered diagnostic and surgical planning software as a service (SaaS) for cerebrovascular diseases, helps neurosurgeons and interventional neuroradiologists make data-driven decisions. VasoGnosis's predictive analytics powered by Big-Data will substantiate the need for life-dependent surgeries that would otherwise be unsupported. To demonstrate clinical relevance and establish commercial relationships, VasoGnosis has entered functional agreements with medical institutions like UMass Memorial and Medical College of Wisconsin. VasoGnosis artificial intelligence algorithms are trained to extract vasculature information from medical images to detect abnormalities. Once an anomaly is found, the algorithm identifies the diseases and shows its location. Our system provides three-dimensional measurements in a customizable radiology report format. After the accurate measurement, our software performs a detailed analysis that determines the necessity of surgical operation. When the surgery is verified by the surgeon, VasoGnosis's surgical planning tool enables surgeons to rehearse the surgery via a blood flow simulator and evaluate patient outcomes. VasoGnosis's SaaS platform is built to provide detection and surgical planning solutions for all cerebrovascular diseases. We started with brain aneurysm, but, we don't intend to stop there. VasoGnosis's business models is a combination of subscription and pay per use: Hospitals will be charged an average annual fee of $50,000 for unlimited use of detection platform. There will be an extra $2,000 charge for each surgical planning case.
FAQ
How much has VasoGnosis raised?
VasoGnosis has raised $114,531 of a $600,000 goal.
Where is VasoGnosis's campaign listed?
The offering is listed on SeedInvest (SI Securities), an SEC-registered Reg CF intermediary.
What are the terms of VasoGnosis's raise?
Convertible Debt, $4M cap, 20% discount, 5% interest, 24-month term.
When does VasoGnosis's offering close?
The stated close date is Aug 14, 2020.
